Combination therapy with Nab-paclitaxel and the interleukin-15 fused with anti-human serum albumin nanobody as a synergistic treatment for colorectal cancer.
- DOI
- 10.1080/21655979.2021.2023997
- Published
- 2022 Jan
- Container
- Bioengineered
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/21655979.2021.2023997,
title = {Combination therapy with Nab-paclitaxel and the interleukin-15 fused with anti-human serum albumin nanobody as a synergistic treatment for colorectal cancer.},
author = {Wu L and Wang W and Tian J and Qi C and Cai Z and Yan W and Xuan S and Shang A},
year = {2022},
journal = {Bioengineered},
doi = {10.1080/21655979.2021.2023997},
url = {https://doi.org/10.1080/21655979.2021.2023997}
}RIS
TY - JOUR TI - Combination therapy with Nab-paclitaxel and the interleukin-15 fused with anti-human serum albumin nanobody as a synergistic treatment for colorectal cancer. AU - Wu L AU - Wang W AU - Tian J AU - Qi C AU - Cai Z AU - Yan W AU - Xuan S AU - Shang A PY - 2022 JO - Bioengineered DO - 10.1080/21655979.2021.2023997 UR - https://doi.org/10.1080/21655979.2021.2023997 ER -
APA
L, W., W, W., J, T., C, Q., Z, C., W, Y., S, X., & A, S. (2022). Combination therapy with Nab-paclitaxel and the interleukin-15 fused with anti-human serum albumin nanobody as a synergistic treatment for colorectal cancer.. Bioengineered. https://doi.org/10.1080/21655979.2021.2023997
Source records
- pubmed · retrieved 2026-09-25T21:28:11.153Z